Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.
Gemini is changing the game by learning from your past chats.The Latest Tech News, Delivered to Your Inbox ...
Why Todd McKinnon thinks it’s ‘naive’ not to prepare for the SaaSpocalypse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results